Emerging evidence also suggests that specific SLiMs derived from or encompassing the alpha-fetoprotein (AFP), a well-known embryo-specific and cancer-related protein, may have antitumor effects in several types of cancer (BC, prostatic cancer, and hepatocellular carcinoma) [30,31,32]. Here, AFP is linked to hepatocellular carcinoma.